[ACL] QoQ Quarter Result on 30-Sep-2019 [#Q1]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Sep-2019
Financial Year
2020
Quarter
30-Sep-2019 [#Q1]
Profit Trend
QoQ-
YoY-
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 164,399 317,904 158,952 244,017 115,435 245,491 129,850 17.01%
PBT 2,690 81,274 40,637 35,108 15,515 -4,217 -100 -
Tax 1,032 24,201 12,101 -9,408 5,163 -1,017 50 651.05%
NP 1,650 57,073 28,537 44,455 20,678 -3,200 -50 -
Tax Rate -38.35% -29.78% -29.78% 26.80% -33.27% - - -
Total Cost 162,749 260,831 130,416 199,562 94,758 248,691 129,900 16.20%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin 1.00 17.95 17.95 18.22 17.91 -1.30 -0.04 -
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS 0.01 0.28 0.20 0.22 0.10 -0.02 0.00 -
EPS Diluted 0.01 0.28 0.20 0.22 0.10 -0.02 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.